Vnitr Lek 2009, 55(6):593-598

Localized tracheobronchial amyloidosis, type AA, and its differentiation from the systemic form of amyloidosis in clinical practice

M. Džingozovová1,*, J. Skřičková1, J. Mačák2, K. Múčková2, Z. Adam3
1 Klinika tuberkulózy a respiračních nemocí Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednostka prof. MUDr. Jana Skřičková, CSc.
2 Ústav patologie Lékařské fakulty MU a FN Brno, pracoviště Bohunice, přednosta prof. MUDr. Jirka Mačák, CSc.
3 Interní hematoloonkologická klinika Lékařské fakulty MU a FN Brno, pracoviště Bohunice, zastupující přednosta prof. MUDr. Jiří Mayer, CSc.

67-year-old patient with chronic obstructive pulmonary disease and chronic pansinusitis suffered from attacks of dyspnea, cough and common cold repeatedly. The chest X-ray was without clear pathology. Because of repeated difficulties, a bronchoscopic examination was made and a diagnosis of amyloidosis was made twice (bronchial biopsy, excision). The patient in our case suffered from a tracheobronchial form of amyloidosis (type AA most probably) together with chronic pansinusitis.

Keywords: classification; incidence; prognosis of amyloidosis; clinical symptoms of pulmonary and systemic amyloidosis; differential diagnostics of various types of amyloidosis in clinical practice

Received: November 13, 2008; Accepted: February 10, 2009; Published: June 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Džingozovová M, Skřičková J, Mačák J, Múčková K, Adam Z. Localized tracheobronchial amyloidosis, type AA, and its differentiation from the systemic form of amyloidosis in clinical practice. Vnitr Lek. 2009;55(6):593-598.
Download citation

References

  1. Fila L, Marel M, Pekárek Z et al. Amyloidóza dýchacího ústrojí. Stud Pneumol Phtiseol 2001; 61: 147-152.
  2. Adam Z. AL amyloidóza a některé další typy amyloidóz. In: Adam Z, Vorlíček J, Vaníček J et al (eds). Diagnostické a léčebné postupy u maligních chorob. Praha: Grada Publishing 2004: 535-539.
  3. Mayer J, Vorlíček J, Skřičková J. Plicní postižení při amyloidóze. In: Mayer J, Skřičková J, Vorlíček J (eds). Postižení plic u imunokompromitovaných nemocných. Diferenciální diagnostika a využití bronchoalveolární laváže. Brno: Institut pro další vzdělávání pracovníků ve zdravotnictví 1995: 113-115.
  4. Adam Z. Monoklonální gamapatie nejasného významu. In: Adam Z, Vorlíček J et al (eds). Speciální onkologie. Brno: MU 2002: 478-481.
  5. Gillmore DJ, Hawkins NP. Amyloidosis and the respiratory tract. Thorax 1999; 54: 444-451. Go to original source... Go to PubMed...
  6. Neben-Wittich MA, Foote RL, Kalra S. External beam radiation therapy for tracheobronchial amyloidosis. Chest 2007; 132: 263-267. Go to original source... Go to PubMed...
  7. Poovaneswaran S, Razak AR, Lockman H et al. Tracheobronchial amyloidosis: utilization of radiotherapy as a treatment modality. Medscape J Med 2008; 10: 42.
  8. Gronych B, Kolek V. Lokalizovaná laryngotracheobronchiální amyloidóza. Stud Pneumol Phtiseol 1995; 55: 41-45.
  9. Klener P. Amyloidóza. In: Klener P, Anděl M, Aschermann M et al (eds). Vnitřní lékařství. Praha: Galén 2001.
  10. Adam Z, Křivanová A, Krejčí M et al. Mnohočetný myelom. In: Adam Z, Vorlíček J et al (eds). Speciální onkologie. Brno: MU 2002: 482-494.
  11. Adam Z. Primární systémová AL-amyloidóza a některé další typy amyloidóz. In: Dítě P et al (eds). Vnitřní lékařství. Praha: Galén 2007.
  12. Tichý M. Primární amyloidóza. Lék Zpr LF UK Hradec Králové 1999; 44: 99-107.
  13. James PU, Stephen JS, Morie A et al. Pulmonary Amyloidosis. The Mayo Clinic Experience from 1980 to 1993. Ann Intern Med 1996; 124: 407-413. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.